Glaukos Corporation

Research Glaukos Corporation (GKOS) on Bullrun: market cap USD 8.35B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGKOS
• ExchangeNYSE
• CountryUnited States
• SectorHealthcare
• IndustryMedical Devices
• CurrencyUSD
• Market capUSD 8.35B
• Financial periodFY2025
• RevenueUSD 507.44M
• Revenue growth32.3%
• Net income-USD 187.69M
• Free cash flow-USD 22.46M
• Gross margin55.7%

Valuation Snapshot

latest market cap is USD 8.35B.

About Glaukos Corporation

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It offers iStent and iStent inject W micro-bypass stents designed to treat mild-to-moderate open-angle glaucoma through the restoration of the natural physiologic outflow pathways for aqueous humor.

Frequently asked questions

What is Glaukos Corporation's market cap?

Glaukos Corporation's market capitalization is USD 8.35B.

What does Glaukos Corporation do?

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally.